BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26348614)

  • 1. Application of infrared-based molecular imaging to a mouse model with head and neck cancer.
    Tanaka N; Lajud SA; Ramsey A; Szymanowski AR; Ruffner R; O'Malley BW; Li D
    Head Neck; 2016 Apr; 38 Suppl 1():E1351-7. PubMed ID: 26348614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in situ imaging of head and neck squamous cell carcinoma using near-infrared fluorescent quantum dot probes conjugated with epidermal growth factor receptor monoclonal antibodies in mice.
    Yang K; Zhao C; Cao YA; Tang H; Bai YL; Huang H; Zhao CR; Chen R; Zhao D
    Oncol Rep; 2012 Jun; 27(6):1925-31. PubMed ID: 22378320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In situ visual imaging and in vivo distribution of head and neck squamous cell carcinoma in mice by near-infrared fluorescent quantum dots epidermal growth factor receptor monoclonal antibody probe].
    Tang H; Yang K; Zhao C; Bai Y; Huang H
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2012 Dec; 30(6):568-73. PubMed ID: 23330362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-infrared fluorescence imaging-guided surgery improves recurrence-free survival rate in novel orthotopic animal model of head and neck squamous cell carcinoma.
    Atallah I; Milet C; Henry M; Josserand V; Reyt E; Coll JL; Hurbin A; Righini CA
    Head Neck; 2016 Apr; 38 Suppl 1():E246-55. PubMed ID: 25546527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
    Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
    Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model.
    Hoeben BA; Molkenboer-Kuenen JD; Oyen WJ; Peeters WJ; Kaanders JH; Bussink J; Boerman OC
    Int J Cancer; 2011 Aug; 129(4):870-8. PubMed ID: 20957635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.
    Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A
    Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vivo imaging of oral squamous cell carcinoma by EGFR monoclonal antibody conjugated near-infrared quantum dots in mice.
    Yang K; Zhang FJ; Tang H; Zhao C; Cao YA; Lv XQ; Chen D; Li YD
    Int J Nanomedicine; 2011; 6():1739-45. PubMed ID: 21980236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved tumor-to-organ ratios of a novel 67Ga-human epidermal growth factor radionuclide conjugate with preadministered antiepidermal growth factor receptor affibody molecules.
    Sandström K; Haylock AK; Velikyan I; Spiegelberg D; Kareem H; Tolmachev V; Lundqvist H; Nestor M
    Cancer Biother Radiopharm; 2011 Oct; 26(5):593-601. PubMed ID: 21834651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery.
    Xu L; Yeudall WA; Yang H
    Acta Biomater; 2017 Jul; 57():251-261. PubMed ID: 28438704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zwitterionic near-infrared fluorophore-conjugated epidermal growth factor for fast, real-time, and target-cell-specific cancer imaging.
    Kim H; Cho MH; Choi HS; Lee BI; Choi Y
    Theranostics; 2019; 9(4):1085-1095. PubMed ID: 30867817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early response monitoring with 18F-FDG PET and cetuximab-F(ab')2-SPECT after radiotherapy of human head and neck squamous cell carcinomas in a mouse model.
    van Dijk LK; Boerman OC; Franssen GM; Lok J; Kaanders JH; Bussink J
    J Nucl Med; 2014 Oct; 55(10):1665-70. PubMed ID: 25236350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
    Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
    Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model.
    Heath CH; Deep NL; Sweeny L; Zinn KR; Rosenthal EL
    Ann Surg Oncol; 2012 Nov; 19(12):3879-87. PubMed ID: 22669455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma.
    Wang WM; Zhao ZL; Ma SR; Yu GT; Liu B; Zhang L; Zhang WF; Kulkarni AB; Sun ZJ; Zhao YF
    PLoS One; 2015; 10(2):e0119723. PubMed ID: 25723392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody.
    van Driel PB; van der Vorst JR; Verbeek FP; Oliveira S; Snoeks TJ; Keereweer S; Chan B; Boonstra MC; Frangioni JV; van Bergen en Henegouwen PM; Vahrmeijer AL; Lowik CW
    Int J Cancer; 2014 Jun; 134(11):2663-73. PubMed ID: 24222574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of mTOR and EGFR targeting in an orthotopic xenograft model of head and neck cancer.
    Bozec A; Ebran N; Radosevic-Robin N; Sudaka A; Monteverde M; Toussan N; Etienne-Grimaldi MC; Nigro CL; Merlano M; Penault-Llorca F; Milano G
    Laryngoscope; 2016 Apr; 126(4):E156-63. PubMed ID: 26597440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma.
    Scher RL
    Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted molecular imaging of head and neck squamous cell carcinoma: a window into precision medicine.
    Wu J; Yuan Y; Tao XF
    Chin Med J (Engl); 2020 Jun; 133(11):1325-1336. PubMed ID: 32404691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats.
    Bao A; Phillips WT; Goins B; McGuff HS; Zheng X; Woolley FR; Natarajan M; Santoyo C; Miller FR; Otto RA
    Otolaryngol Head Neck Surg; 2006 Dec; 135(6):853-7. PubMed ID: 17141073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.